Member Info for one4one

Https://www.msn.com/en-gb/money/other/suspicious-timing-580m-oil-bet-placed-minutes-before-trump-s-iran-post-as-white-house-faces-questions/ar-AA1Zk9gR?ocid=msedgdhp&pc=HCTS&cvid=69c2f60b3e5f4deb94bf9b770d64a529&ei=66

The USA stance on lower drug prices for usa citizens......has just hit a flaw as big pharma jack up prices due to geo-political tensions 🐭

Https://www.msn.com/en-gb/news/world/iran-s-strike-on-diego-garcia-will-be-ringing-alarm-bells-across-europe/ar-AA1Z802d?ocid=msedgdhp&pc=HCTS&cvid=69befa862fdd4caba82112ab9aedbe0d&ei=71

He should declare Victory and go home then blame it on Fake news,

Lostheplot ....honest question ..trust me there is no desire for mead tech at this present moment in time especially interrupting the early stage of the Clinical trial ! millions of billions of shares has been placed for the funding of hemogenyx state of the art laboratory surely that could manufactor the 3 patients enrolled🐭

Hereford bulls of with their bullocks🐭

Having a hamlet moment as the incest crew shaft them selves ! "handbags guys keep up the entertainment🐭

ABH you should update your toolbox from imperial to Metric, "passes a adjustable spanner ! you are correct G-rex Manufacturing platform will cater for

car-T products approved by the FDA of which is autologous. (Hemogenyx ) is Prime example. But, allogeneic CAR-T therapies are being looked at for their potential to offer treatments right away.(Allogenic) This could make them more accessible and cheaper. so B P are monitoring before commitment on the grounds of Affordability....Sustainability....Accessibility until proven patients own b/cells or Donor/cells is the Answer evolving🐭

@Brentw1...Play the Ball & Not the Man

After every conference vlad will relay the same format " We are in negotiations with big pharma ! "Hemo will not be talking to Eli-lily"🐭

Plans to tap the n/sea oil providing it is signed of by the energy sectary ? then the next issue Oil from Rosebank would be exported because the UK now lacks the refinery capacity to process it ?

The future of cell /gene therapy is being held back by a fragmentary regulatory system based on accessibility/affordability of which is evolving t/wards scalability "Autologous Vs Allogeneic: 🐭

CDX i was not aware that it was a proven science and had gained c/t status can you expand HereforHemo🐭

Please expand with your vast knowledge of clinical trials Haywain🐭

Vlad has started the c/t with Autologous custom therapy with a positive advancement, Now waiting for Made Science to come on line to step/speed up the Manufacturing process, Will that be off the shelf allogeneic ? the answer to that question is unknown until hemogenyx forwards a company up-date !

So brace yourself if made adopt the allogenic route of manufacturing a different approach to Autologous this may spook the Fda & present a clinical Hold/caveat.

Time for that update vlad🐭

Djt has lifted sanctions of Russia giving russia top dollar on the spot price of oil/Iran will let China/India through the straights/Dlt ace is Venezuela heavy oil is pricy to refine !

Scratching the bears butt

Overseas companies must get their own regulatory approval

access to the blueprint will not give Estonia clinical approval

vlad will get a royalty payment but not the full valuation

the full valuation payment will be staged pending Data

ive done my research have you?🐭

The polb science is certainly a metric tool to be used for the bypass of CRS, as cell therapy evolves manufacturing of the patients own cells/donor cells ?

you may find the link interesting /though you may find this post as derogative towards polb if so Scroll on by🐭

https://int.livhospital.com/autologous-vs-allogeneic-vital-car-t-facts/

Oi get your facts rite, i have not sold hemo to invest else where actually from hemo ipo i have supported the placing of millions of shares only to find lupus/cdx fall by the wayside⚓er

This romantic fool is twisting word for his pleasure ! jog on to your own forum & preach to your divine congregation with sermons of nonscience.